N-(4-[18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors

被引：6
|
作者：
Garcia, Gonzalo [1 ]
Abet, Valentina [1 ]
Alajarin, Ramon [1 ]
Alvarez-Builla, Julio [1 ]
Delgado, Mercedes [2 ]
Garcia-Garcia, Luis [2 ]
Bascunana-Almarcha, Pablo [2 ]
Pena-Salcedo, Carmen [3 ]
Kelly, James [3 ]
Pozo, Miguel A. [2 ,3 ]
机构：
[1] Univ Alcala, Dept Quim Organ, Madrid 28871, Spain
[2] Inst Pluridisciplinar UCM, CAI Cartog Cerebral, Madrid 28040, Spain
[3] Inst Tecnol PET, Madrid 28040, Spain
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2014年 / 85卷
关键词：
5-HT1A; Positron emission tomography; Fluorine-18; Radioligand; N-(4-[F-18]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides; NUCLEOPHILIC AROMATIC-SUBSTITUTION; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; RADIOACTIVE METABOLITES; TISSUE DISTRIBUTION; ARYL HALIDES; HUMAN PLASMA; BRAIN; WAY-100635; RADIOLIGAND;
D O I：
10.1016/j.ejmech.2014.07.096
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
N-(4-[F-18]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides were prepared by labeling their 4-nitropyridin-2-yl precursors through nitro substitution by the F-18 anion. In vitro and in vivo tests showed that the cyclohexanecarboxamide derivative is a reversible, selective and high affinity 5-HT1A receptor antagonist (IC50 = 0.29 nM, k(i) = 0.18 nM) with high brain uptake, slow brain clearance and stability to defluorination when compared with conventional standards. This PET radioligand is a promising candidate for an improved in vivo quantification of 5-HT1A receptors in neuropsychiatric disorders. (C) 2014 Published by Elsevier Masson SAS.
引用
收藏
页码：795 / 806
页数：12
相关论文
共 50 条
  • [31] (S)-N-TERT-BUTYL-3-(4-(2-METHOXYPHENYL)-PIPERAZIN-1-YL)-2-PHENYLPROPANAMIDE [(S)-WAY-100135] - A SELECTIVE ANTAGONIST AT PRESYNAPTIC AND POSTSYNAPTIC 5-HT(1A) RECEPTORS
    CLIFFE, IA
    BRIGHTWELL, CI
    FLETCHER, A
    FORSTER, EA
    MANSELL, HL
    REILLY, Y
    ROUTLEDGE, C
    WHITE, AC
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) : 1509 - 1510
  • [32] IN VITRO TOCOLYTIC ACTIVITY OF 3-BENZAMIDO-1-(4-(2-METHOXYPHENYL)-PIPERAZIN-1-YL)-PROPYL-2-ISOPROPYLCARBOXAMIDE
    Lucky, Okunrobo O.
    Omonkhelin, Owolabi J.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2009, 43 (01) : 16 - 18
  • [33] 3-(Adamantan-1-yl)-4-ethyl-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}1H-1,2,4-triazole-5(4H)-thione
    El-Emam, Ali A.
    Al-Tuwaijri, Hanaa M.
    Al-Abdullah, Ebtehal S.
    Kumar, C. S. Chidan
    Fun, Hoong-Kun
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O25 - +
  • [34] Synthesis of 2-[4-(4-Chlorophenyl)piperazin-1-yl]-2-methylpropanoic Acid Ethyl Ester
    Pati, Hari N.
    Mishra, Bijay K.
    Satam, Vijay S.
    MOLBANK, 2009, (03)
  • [35] SYNTHESIS AND RADIOLABELING OF N-[4-[4-(2-[11C]METHOXYPHENYL)PIPERAZIN-1-YL]BUTYL] BENZO[b]THIOPHENE-2-CARBOXAMIDE, A POTENTIAL RADIOTRACER FOR D3 RECEPTOR IMAGING WITH PET
    Kuhnast, B.
    Demphel, S.
    Besret, L.
    Coulon, C.
    Ottaviani, M.
    Guillermier, M.
    Valette, H.
    Bottlaender, M.
    Dolle, F.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S166 - S166
  • [36] Synthesis and radiolabeling of N-[4-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide -: a potential radiotracer for D3 receptor imaging with PET
    Kuhnast, Bertrand
    Valette, Heric
    Besret, Laurent
    Demphel, Stephane
    Coulon, Christine
    Ottaviani, Michele
    Guillermier, Martine
    Bottlaender, Michel
    Dolle, Fredreic
    NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (06) : 785 - 795
  • [37] Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys
    Martelle, Jennifer L.
    Claytor, Renee
    Ross, Jason T.
    Reboussin, Beth A.
    Newman, Amy Hauck
    Nader, Michael A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (02): : 573 - 582
  • [38] Synthesis, molecular docking and biological potentials of new 2-(4-(2-chloroacetyl) piperazin-1-yl)-N-(2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl)acetamide derivatives
    Mehta, Shinky
    Kumar, Sanjiv
    Marwaha, Rakesh Kumar
    Narasimhan, Balasubramanian
    Ramasamy, Kalavathy
    Lim, Siong Meng
    Shah, Syed Adnan Ali
    Mani, Vasudevan
    BMC CHEMISTRY, 2019, 13 (01)
  • [39] Synthesis, molecular docking and biological potentials of new 2-(4-(2-chloroacetyl) piperazin-1-yl)-N-(2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl)acetamide derivatives
    Shinky Mehta
    Sanjiv Kumar
    Rakesh Kumar Marwaha
    Balasubramanian Narasimhan
    Kalavathy Ramasamy
    Siong Meng Lim
    Syed Adnan Ali Shah
    Vasudevan Mani
    BMC Chemistry, 13
  • [40] Synthesis and antimicrobial activity of some novel N-[2-substitutedbenzoxazol-5-yl]-2-[4-substituted- piperazin-1-yl]acetamides
    Arisoy, Mustafa
    Temiz-Arpaci, Ozlem
    Kaynak-Onurdag, Fatma
    Yildiz, Ilkay
    Aki-Sener, Esin
    Yalcin, Ismail
    Abbasoglu, Ufuk
    DRUGS OF THE FUTURE, 2007, 32 : 127 - 128
12345